Progress in Optical Methods for the Detection of Two Core Blood Biomarkers of Alzheimer’s Disease: Amyloid-Beta and Tau Proteins
Alzheimer’s disease (AD) is the most common neurodegenerative disorder worldwide. Early diagnosis of AD is crucial for delaying disease progression and improving patients’ quality of life. Blood biomarkers, particularly amyloid-beta (Aβ) and Tau proteins along with their phosphorylated isoforms, show advantages such as...